These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Physical and functional interaction between ribosomal protein L11 and the tumor suppressor ARF. Dai MS; Challagundla KB; Sun XX; Palam LR; Zeng SX; Wek RC; Lu H J Biol Chem; 2012 May; 287(21):17120-17129. PubMed ID: 22467867 [TBL] [Abstract][Full Text] [Related]
83. Nuclear stabilization of p53 requires a functional nucleolar surveillance pathway. Hannan KM; Soo P; Wong MS; Lee JK; Hein N; Poh P; Wysoke KD; Williams TD; Montellese C; Smith LK; Al-Obaidi SJ; Núñez-Villacís L; Pavy M; He JS; Parsons KM; Loring KE; Morrison T; Diesch J; Burgio G; Ferreira R; Feng ZP; Gould CM; Madhamshettiwar PB; Flygare J; Gonda TJ; Simpson KJ; Kutay U; Pearson RB; Engel C; Watkins NJ; Hannan RD; George AJ Cell Rep; 2022 Nov; 41(5):111571. PubMed ID: 36323262 [TBL] [Abstract][Full Text] [Related]
84. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Zhang Y; Wolf GW; Bhat K; Jin A; Allio T; Burkhart WA; Xiong Y Mol Cell Biol; 2003 Dec; 23(23):8902-12. PubMed ID: 14612427 [TBL] [Abstract][Full Text] [Related]
85. Nucleolar stress: From development to cancer. Lafita-Navarro MC; Conacci-Sorrell M Semin Cell Dev Biol; 2023 Feb; 136():64-74. PubMed ID: 35410715 [TBL] [Abstract][Full Text] [Related]
86. NOL12 Repression Induces Nucleolar Stress-Driven Cellular Senescence and Is Associated with Normative Aging. Pinho M; Macedo JC; Logarinho E; Pereira PS Mol Cell Biol; 2019 Jun; 39(12):. PubMed ID: 30988155 [TBL] [Abstract][Full Text] [Related]
87. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Itahana K; Bhat KP; Jin A; Itahana Y; Hawke D; Kobayashi R; Zhang Y Mol Cell; 2003 Nov; 12(5):1151-64. PubMed ID: 14636574 [TBL] [Abstract][Full Text] [Related]
88. Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network. Daftuar L; Zhu Y; Jacq X; Prives C PLoS One; 2013; 8(7):e68667. PubMed ID: 23874713 [TBL] [Abstract][Full Text] [Related]
89. Non-genotoxic activation of p53 through the RPL11-dependent ribosomal stress pathway. Morgado-Palacin L; Llanos S; Urbano-Cuadrado M; Blanco-Aparicio C; Megias D; Pastor J; Serrano M Carcinogenesis; 2014 Dec; 35(12):2822-30. PubMed ID: 25344835 [TBL] [Abstract][Full Text] [Related]
90. Recruitment of RPL11 at promoter sites of p53-regulated genes upon nucleolar stress through NEDD8 and in an Mdm2-dependent manner. Mahata B; Sundqvist A; Xirodimas DP Oncogene; 2012 Jun; 31(25):3060-71. PubMed ID: 22081073 [TBL] [Abstract][Full Text] [Related]
91. Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications. Wang W; Nag S; Zhang X; Wang MH; Wang H; Zhou J; Zhang R Med Res Rev; 2015 Mar; 35(2):225-85. PubMed ID: 25164622 [TBL] [Abstract][Full Text] [Related]
92. Identification of ribosomal protein S25 (RPS25)-MDM2-p53 regulatory feedback loop. Zhang X; Wang W; Wang H; Wang MH; Xu W; Zhang R Oncogene; 2013 May; 32(22):2782-91. PubMed ID: 22777350 [TBL] [Abstract][Full Text] [Related]
93. Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate. Brighenti E; Giannone FA; Fornari F; Onofrillo C; Govoni M; Montanaro L; Treré D; Derenzini M Oncotarget; 2016 Sep; 7(39):63226-63241. PubMed ID: 27557515 [TBL] [Abstract][Full Text] [Related]
94. The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway. Bailly A; Perrin A; Bou Malhab LJ; Pion E; Larance M; Nagala M; Smith P; O'Donohue MF; Gleizes PE; Zomerdijk J; Lamond AI; Xirodimas DP Oncogene; 2016 Jan; 35(4):415-26. PubMed ID: 25867069 [TBL] [Abstract][Full Text] [Related]
95. Ribosomal protein RPL11 haploinsufficiency causes anemia in mice via activation of the RP-MDM2-p53 pathway. Franklin DA; Liu S; Jin A; Cui P; Guo Z; Arend KC; Moorman NJ; He S; Wang GG; Wan YY; Zhang Y J Biol Chem; 2023 Jan; 299(1):102739. PubMed ID: 36435197 [TBL] [Abstract][Full Text] [Related]
96. Aberrant ribosome biogenesis activates c-Myc and ASK1 pathways resulting in p53-dependent G1 arrest. Kim HD; Kim TS; Kim J Oncogene; 2011 Jul; 30(30):3317-27. PubMed ID: 21383696 [TBL] [Abstract][Full Text] [Related]
97. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis. Liu S; Tackmann NR; Yang J; Zhang Y Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574 [TBL] [Abstract][Full Text] [Related]
98. Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11. Sasaki M; Kawahara K; Nishio M; Mimori K; Kogo R; Hamada K; Itoh B; Wang J; Komatsu Y; Yang YR; Hikasa H; Horie Y; Yamashita T; Kamijo T; Zhang Y; Zhu Y; Prives C; Nakano T; Mak TW; Sasaki T; Maehama T; Mori M; Suzuki A Nat Med; 2011 Jul; 17(8):944-51. PubMed ID: 21804542 [TBL] [Abstract][Full Text] [Related]
99. JHDM1B expression regulates ribosome biogenesis and cancer cell growth in a p53 dependent manner. Penzo M; Casoli L; Pollutri D; Sicuro L; Ceccarelli C; Santini D; Taffurelli M; Govoni M; Brina D; Trerè D; Montanaro L Int J Cancer; 2015 Mar; 136(5):E272-81. PubMed ID: 25273595 [TBL] [Abstract][Full Text] [Related]
100. Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2. Dai MS; Sun XX; Lu H Mol Cell Biol; 2008 Jul; 28(13):4365-76. PubMed ID: 18426907 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]